Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Cash from Investing Activities (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Cash from Investing Activities readings, the most recent being -$2.0 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 110.12% to -$2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$37.8 million, a 106.94% decrease, with the full-year FY2025 number at -$37.8 million, down 106.94% from a year prior.
  • Cash from Investing Activities hit -$2.0 million in Q4 2025 for Aligos Therapeutics, down from $47.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $47.7 million in Q3 2025 to a low of -$88.6 million in Q1 2024.
  • Median Cash from Investing Activities over the past 5 years was $4.8 million (2021), compared with a mean of -$1.7 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 723.17% in 2022 and later soared 285414.29% in 2024.
  • Aligos Therapeutics' Cash from Investing Activities stood at -$16.5 million in 2021, then surged by 170.42% to $11.6 million in 2022, then tumbled by 100.06% to -$7000.0 in 2023, then soared by 285414.29% to $20.0 million in 2024, then crashed by 110.12% to -$2.0 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$2.0 million (Q4 2025), $47.7 million (Q3 2025), and -$39.4 million (Q2 2025) per Business Quant data.